Insights

Strategic Partnerships Leverage Seven Bridges’ strong collaboration history with NIH and BioCompute Object to position integrated genomics data workflows and regulatory-ready NGS solutions to research institutes, biopharma, and contract research organizations seeking compliant analytics platforms.

Regulatory Standards Target customers needing standardized, auditable genomics reporting by highlighting Seven Bridges' work on the BCO standard and its award-winning app for generating BCOs, which can shorten regulatory timelines and improve audit readiness.

ScaleableBioinformatics Promote the platform’s capacity to connect global biomedical data and enable large-scale analysis for precision medicine programs, appealing to academic centers, hospitals, and pharma players pursuing big data, cloud-based analytics, and cross-institution collaboration.

Cloud & Data Tools Position the tech stack emphasis on Databricks, ELK, Istio, and cloud-ready workflows to IT and data science leaders as a modern, secure, and scalable environment for research pipelines, data governance, and reproducible analyses.

Growth & Expansion Capitalize on Seven Bridges’ recent corporate evolution and funding activity, including acquisitions and new ventures, to present potential partners and customers with a forward-looking roadmap, broader service scope, and expanded geographic reach through Velsera and related entities.

Similar companies to Seven Bridges

Seven Bridges Tech Stack

Seven Bridges uses 8 technology products and services including HubSpot Analytics, Pendo, Ansible, and more. Explore Seven Bridges's tech stack below.

Media & News

Seven Bridges's Email Address Formats

Seven Bridges uses at least 3 format(s):
Seven Bridges Email FormatsExamplePercentage
FLast@bridgesbyepoch.comJDoe@bridgesbyepoch.com
91%
Last@bridgesbyepoch.comDoe@bridgesbyepoch.com
7%
First.Last@bridgesbyepoch.comJohn.Doe@bridgesbyepoch.com
2%
First.Last@sbgenomics.comJohn.Doe@sbgenomics.com
97%
FLast@sbgenomics.comJDoe@sbgenomics.com
1%
First@sbgenomics.comJohn@sbgenomics.com
1%
Last.First@sbgenomics.comDoe.John@sbgenomics.com
1%
First.Last@sevenbridges.comJohn.Doe@sevenbridges.com
61%
FirstLast@sevenbridges.comJohnDoe@sevenbridges.com
29%
Last@sevenbridges.comDoe@sevenbridges.com
8%
FLast@sevenbridges.comJDoe@sevenbridges.com
2%

Frequently Asked Questions

What is Seven Bridges's official website and social media links?

Minus sign iconPlus sign icon
Seven Bridges's official website is sevenbridges.com and has social profiles on LinkedIn.

How much revenue does Seven Bridges generate?

Minus sign iconPlus sign icon
As of July 2026, Seven Bridges's annual revenue is estimated to be $10M - $25M.

What is Seven Bridges's SIC code NAICS code?

Minus sign iconPlus sign icon
Seven Bridges's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Seven Bridges have currently?

Minus sign iconPlus sign icon
As of July 2026, Seven Bridges has approximately 145 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Technology Officer: D. R.Chief Communications Officer: L. G.Chief Financial Officer: M. F.. Explore Seven Bridges's employee directory with LeadIQ.

What industry does Seven Bridges belong to?

Minus sign iconPlus sign icon
Seven Bridges operates in the Biotechnology Research industry.

What technology does Seven Bridges use?

Minus sign iconPlus sign icon
Seven Bridges's tech stack includes HubSpot AnalyticsPendoAnsibleCookiebotGoogle BigQueryFigmaAmazon SageMakerAtlassian Confluence.

What is Seven Bridges's email format?

Minus sign iconPlus sign icon
Seven Bridges's email format typically follows the pattern of FLast@bridgesbyepoch.com. Find more Seven Bridges email formats with LeadIQ.

When was Seven Bridges founded?

Minus sign iconPlus sign icon
Seven Bridges was founded in 2009.
Seven Bridges logo

Seven Bridges

Biotechnology ResearchMassachusetts, United States51-200 Employees

Seven Bridges offers a unified bioinformatics platform, analytic tools, and services designed to help researchers interpret biomedical data to advance precision medicine. Its customers span academic institutions, biotech firms, government agencies, hospitals, and pharmaceutical companies, supporting discovery and drug development. Through collaborations with major genomics projects, the company connects diverse biomedical information to enable scalable data analysis.

Based in Boston, Massachusetts, Seven Bridges operates in the biotechnology research sector and has engaged in collaborations with public research initiatives, including NIH's INCLUDE project since 2020. In September 2023, it teamed with the BioCompute Object community to advance a standard for communicating complex next-generation sequencing workflows for regulatory review, and to develop an accompanying app that generates BCOs from these workflows.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    Seven Bridges's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $10M - $25M

    Seven Bridges's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.